SCHEMBL5374207

SCHEMBL5374207

NC(=O)c1cc2cc(N3CCC(Cc4ccccc4)CC3)[nH]c2cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.52
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
HTR2B P41595 1/20 0.47
MAPK14 Q16539 1/20 0.47
GAA P10253 2/20 0.47
ALDH1A1 P00352 1/20 0.46
TP53 P04637 1/20 0.46
CYP3A4 P08684 1/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
GRIN2D O15399 2/20 0.45
GRIN3B O60391 2/20 0.45
GRIN1 Q05586 2/20 0.45
GRIN2A Q12879 2/20 0.45
GRIN2B Q13224 2/20 0.45
GRIN2C Q14957 2/20 0.45
GRIN3A Q8TCU5 2/20 0.45
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5387265 0.96 GPR84 (0.52) GPR84CYP2C9CYP2C19HTR2BMAPK14
SCHEMBL5376292 0.90 MAPK14 (0.46) MAPK14MEN1KMT2AGRIN2DGRIN3B
SCHEMBL5201673 0.86 MEN1 (0.59) GPR84CYP2C9CYP2C19MAPK14MEN1
SCHEMBL5203581 0.83 GAA (0.54) GPR84CYP2C9CYP2C19GAAALDH1A1
SCHEMBL5733660 0.83 GAA (0.54) GPR84CYP2C9CYP2C19GAAALDH1A1
SCHEMBL5377680 0.83 CYP2C9 (0.45) GPR84CYP2C9CYP2C19HTR2BMAPK14
SCHEMBL5376322 0.82 GPR84 (0.51) GPR84CYP2C9CYP2C19HTR2BMAPK14
SCHEMBL5383885 0.82 GPR84 (0.51) GPR84CYP2C9CYP2C19HTR2BMAPK14
SCHEMBL5377683 0.81 CYP2C9 (0.45) GPR84CYP2C9CYP2C19HTR2BMAPK14
SCHEMBL5378646 0.80 MEN1 (0.52) GPR84GAAMEN1KMT2AGRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189739-B2 Compounds and methods to treat cardiac failure and other disorders SCIOS, INC. (US) 2007-03-13 US disclosed
EP-1080078-B1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC (US) 2006-02-01 EP disclosed
US-6589954-B1 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful SCIOS, INC. 2003-07-08 US disclosed
US-6340685-B1 ANTIINFLAMMATORY AGENTS SCIOS, INC. 2002-01-22 US disclosed
EP-1080078-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 2001-03-07 EP disclosed
WO-1999061426-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 1999-12-02 WO disclosed